Cardiomyopathies: from genetics to the prospect of treatment (Q34444836)

2 August 2017

1 reference

title

Cardiomyopathies: from genetics to the prospect of treatment (English)

1 reference

2 August 2017

3

H A Katus

1 reference

2 August 2017

W M Franz

1

1 reference

PubMed ID

11716909

2 August 2017

O J Müller

series ordinal

2

1 reference

PubMed ID

11716909

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

2 August 2017

1 reference

2 August 2017

358

1 reference

2 August 2017

9293

1 reference

2 August 2017

1627-1637

1 reference

Heart failure: a growing public health problem

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

The heart failure epidemic: exactly how big is it?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Underlying causes and survival in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Spectrum and outcome of congestive heart failure in a hospitalized population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Epidemiology of Hypertrophic Cardiomyopathy–Related Death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Apical hypertrophic cardiomyopathy: the continuing saga

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Natural history of hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Effects of two hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Hypercontractile properties of cardiac muscle fibers in a knock-in mouse model of cardiac myosin-binding protein-C

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Actin mutations in dilated cardiomyopathy, a heritable form of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Angiotensin-Converting Enzyme and Heart Chymase gene Polymorphisms in Hypertrophic Cardiomyopathy**This study was supported by a grant-in-aid from the Bundesministerium für Bildung und Forschung and the European commission grant (ERBCHBGCT 940725

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Angiotensinogen gene polymorphism in Japanese patients with hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Ventricular pacing with premature excitation for treatment of hypertensive-cardiac hypertrophy with cavity-obliteration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Clinical course of hypertrophic cardiomyopathy in a regional United States cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Cardiomyopathy. Diagnosis and management of dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Frequency and phenotypes of familial dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Desmin mutation responsible for idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Dilated cardiomyopathy and sensorineural hearing loss: a heritable syndrome that maps to 6q23-24.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Missense mutations in desmin associated with familial cardiac and skeletal myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Maternally inherited cardiomyopathy: an atypical presentation of the mtDNA 12S rRNA gene A1555G mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Characterization of a Unique Genetic Variant in the β1-adrenoceptor Gene and Evaluation of its Role in Idiopathic Dilated Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Blunted cardiac responses to receptor activation in subjects with Thr164Ile beta(2)-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Pacing Therapies in Congestive Heart Failure II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour holter electrocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Study Group on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy of the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of th

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906657-0

7 January 2021

10.1016/S0140-6736(01)06657-0

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11716909